Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1420042823;42824;42825 chr2:178633901;178633900;178633899chr2:179498628;179498627;179498626
N2AB1255937900;37901;37902 chr2:178633901;178633900;178633899chr2:179498628;179498627;179498626
N2A1163235119;35120;35121 chr2:178633901;178633900;178633899chr2:179498628;179498627;179498626
N2B513515628;15629;15630 chr2:178633901;178633900;178633899chr2:179498628;179498627;179498626
Novex-1526016003;16004;16005 chr2:178633901;178633900;178633899chr2:179498628;179498627;179498626
Novex-2532716204;16205;16206 chr2:178633901;178633900;178633899chr2:179498628;179498627;179498626
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: M
  • RefSeq wild type transcript codon: ATG
  • RefSeq wild type template codon: TAC
  • Domain: Ig-92
  • Domain position: 59
  • Structural Position: 140
  • Q(SASA): 0.1562
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
M/R None None 0.106 N 0.719 0.529 0.635165634531 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
M/A 0.9409 likely_pathogenic 0.949 pathogenic -2.639 Highly Destabilizing 0.014 N 0.544 neutral None None None None N
M/C 0.9256 likely_pathogenic 0.9406 pathogenic -2.629 Highly Destabilizing 0.628 D 0.721 prob.delet. None None None None N
M/D 0.995 likely_pathogenic 0.9967 pathogenic -1.838 Destabilizing 0.356 N 0.789 deleterious None None None None N
M/E 0.9552 likely_pathogenic 0.9671 pathogenic -1.65 Destabilizing 0.136 N 0.723 prob.delet. None None None None N
M/F 0.367 ambiguous 0.3702 ambiguous -1.111 Destabilizing 0.072 N 0.568 neutral None None None None N
M/G 0.9799 likely_pathogenic 0.9869 pathogenic -3.121 Highly Destabilizing 0.136 N 0.737 prob.delet. None None None None N
M/H 0.9464 likely_pathogenic 0.9586 pathogenic -2.401 Highly Destabilizing 0.628 D 0.775 deleterious None None None None N
M/I 0.2829 likely_benign 0.2649 benign -1.269 Destabilizing None N 0.298 neutral N 0.286285887 None None N
M/K 0.8151 likely_pathogenic 0.8461 pathogenic -1.564 Destabilizing 0.106 N 0.632 neutral N 0.512000938 None None N
M/L 0.1796 likely_benign 0.1751 benign -1.269 Destabilizing None N 0.283 neutral N 0.425906051 None None N
M/N 0.9639 likely_pathogenic 0.9708 pathogenic -1.789 Destabilizing 0.628 D 0.771 deleterious None None None None N
M/P 0.9975 likely_pathogenic 0.9982 pathogenic -1.705 Destabilizing 0.628 D 0.773 deleterious None None None None N
M/Q 0.835 likely_pathogenic 0.8632 pathogenic -1.585 Destabilizing 0.628 D 0.656 neutral None None None None N
M/R 0.8246 likely_pathogenic 0.8532 pathogenic -1.429 Destabilizing 0.106 N 0.719 prob.delet. N 0.512000938 None None N
M/S 0.9625 likely_pathogenic 0.9689 pathogenic -2.494 Highly Destabilizing 0.136 N 0.623 neutral None None None None N
M/T 0.8846 likely_pathogenic 0.9056 pathogenic -2.166 Highly Destabilizing 0.024 N 0.615 neutral N 0.511490213 None None N
M/V 0.1993 likely_benign 0.2026 benign -1.705 Destabilizing 0.001 N 0.345 neutral N 0.435452602 None None N
M/W 0.7712 likely_pathogenic 0.8133 pathogenic -1.247 Destabilizing 0.864 D 0.715 prob.delet. None None None None N
M/Y 0.7587 likely_pathogenic 0.8013 pathogenic -1.313 Destabilizing 0.356 N 0.721 prob.delet. None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.